** = Publikationen gelistet in SCI/SSCI/Pubmed
** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639
Doi: 10.1007/s00392-024-02523-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Azhar, K; Ramirez-Obermayer, A; Sourij, C; Knoll, L; Andritz, E; Kojzar, H; Müller, A; Moser, O; Tripolt, NJ; Pferschy, PN; Aziz, F; Sourij, H
Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes-Two-year follow-up of the randomised controlled InterFast-2 trial.
Diabetes Obes Metab. 2025; 27(3):1605-1608
Doi: 10.1111/dom.16158
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, H; Azhar, K; Aberer, F; Sourij, C; Tripolt, NJ; Kojzar, H; Pferschy, PN; Buchmann, A; Aziz, F; Khalil, M
Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study.
Diabetes Obes Metab. 2025;
Doi: 10.1111/dom.16340
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aziz, F; Tripolt, NJ; Pferschy, PN; Scharnagl, H; Abdellatif, M; Oulhaj, A; Benedikt, M; Kolesnik, E; von, Lewinski, D; Sourij, H
Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2024; 23(1): 145
Doi: 10.1186/s12933-024-02221-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Benedikt, M; Aziz, F; Fröschl, T; Strohhofer, C; Kolesnik, E; Tripolt, N; Pferschy, P; Wallner, M; Bugger, H; Zirlik, A; Scherr, D; Sourij, H; von, Lewinski, D
Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin.
Sci Rep. 2024; 14(1): 15083
Doi: 10.1038/s41598-024-64175-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Benedikt, M; Oulhaj, A; Rohrer, U; Manninger, M; Tripolt, NJ; Pferschy, PN; Aziz, F; Wallner, M; Kolesnik, E; Gwechenberger, M; Martinek, M; Nürnberg, M; Roithinger, FX; Steinwender, C; Widkal, J; Leiter, S; Zirlik, A; Stühlinger, M; Scherr, D; Sourij, H; von, Lewinski, D
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-Ds.
NEJM Evid. 2024; 3(10):EVIDoa2400147
Doi: 10.1056/EVIDoa2400147
PubMed
FullText
FullText_MUG
** Pammer, A; Obermayer, A; Stadler, JT; Pferschy, PN; Tripolt, NJ; Habisch, H; Madl, T; Sourij, H; Marsche, G
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial.
Cardiovasc Diabetol. 2024; 23(1): 339
Doi: 10.1186/s12933-024-02426-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Aziz, F; Tripolt, NJ; Siller-Matula, J; Pferschy, PN; Kolesnik, E; Wallner, M; Eyileten, C; Postula, M; Oulhaj, A; Sourij, H; von Lewinski, D; EMMY study group
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trial.
Hellenic J Cardiol. 2024; 75: 3-8.
Doi: 10.1016/j.hjc.2023.05.007
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Oulhaj, A; Aziz, F; Tripolt, NJ; Aberer, F; Pferschy, PN; Postula, M; Drexel, H; Benedikt, M; Kolesnik, E; Pieber, TR; Bugger, H; von, Lewinski, D; Sourij, H
Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.
Diabetes Obes Metab. 2024; 26(5): 1971-1975.
Doi: 10.1111/dom.15477
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Mueller, A; Andritz, E; Wurm, E; Grothoff, A; Fröhlich-Reiterer, E; Pferschy, P; Fritsch, M; Tripolt, N; Schierbauer, J; Hofer, SE; Sanfilippo, S; Voit, T; Sourij, H
Performance of Automated Insulin Delivery systems during a winter ski camp in children and adolescents with type 1 diabetes: the InSki trial
DIABETOLOGIA. 2024; 67: S242-S242.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN.
[Poster]
Web of Science
** Aziz, F; Tripolt, NJ; Pferschy, PN; Kolesnik, E; Mangge, H; Curcic, P; Hermann, M; Meinitzer, A; von, Lewinski, D; Sourij, H, , EMMY, Investigators
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial.
Cardiovasc Diabetol. 2023; 22(1): 184
Doi: 10.1186/s12933-023-01920-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Benedikt, M; Mangge, H; Aziz, F; Curcic, P; Pailer, S; Herrmann, M; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Wallner, M; Zirlik, A; Sourij, H; von, Lewinski, D
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trial.
Cardiovasc Diabetol. 2023; 22(1): 166
Doi: 10.1186/s12933-023-01904-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Lenz, J; Mursic, I; Sternad, C; Hönger, L; Ziko, H; Pferschy, PN; Tripolt, N; Sourij, H
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study).
Diabetes Technol Ther. 2023; 25(3):161-168
Doi: 10.1089/dia.2022.0422
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Müller, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Habisch, H; Madl, T; Pieber, T; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Diabetes Care. 2023; 46(2):463-468
Doi: 10.2337/dc22-1622
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Paar, M; Aziz, F; Sourij, C; Tripolt, NJ; Kojzar, H; Müller, A; Pferschy, P; Obermayer, A; Banfic, T; Di, Geronimo, Quintero, B; Goswami, N; Schlagenhauf, A; Köstenberger, M; Bärnthaler, T; Wagner, T; Hrzenjak, A; Wonisch, W; Reibnegger, G; Raggam, RB; Sourij, H; Cvirn, G
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination.
Viruses. 2023; 15(1): 10
Doi: 10.3390/v15010010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ryder, REJ; Laubner, K; Benes, M; Haluzik, M; Munro, L; Frydenberg, H; Teare, JP; Ruban, A; Fishman, S; Santo, E; Stengel, R; De, Jonge, C; Greve, JW; Cohen, RV; Aboud, CM; Holtmann, GJ; Rich, G; McMaster, JJ; Battelino, T; Kotnik, P; Byrne, JP; Mason, JC; Bessell, J; Bascomb, J; Kow, L; Collins, J; Chisholm, J; Pferschy, PN; Sourij, H; Cull, ML; Wyres, MC; Drummond, R; McGowan, B; Amiel, SA; Yadagiri, M; Sen, Gupta, P; Aberle, J; Seufert, J
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
Diabetes Care. 2023; 46(4): e89-e91.
Doi: 10.2337/dc22-1952
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tripolt, NJ; Hofer, SJ; Pferschy, PN; Aziz, F; Durand, S; Aprahamian, F; Nirmalathasan, N; Waltenstorfer, M; Eisenberg, T; Obermayer, AMA; Riedl, R; Kojzar, H; Moser, O; Sourij, C; Bugger, H; Oulhaj, A; Pieber, TR; Zanker, M; Kroemer, G; Madeo, F; Sourij, H
Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People-A Cohort Trial.
Nutrients. 2023; 15(3):
Doi: 10.3390/nu15030511
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Kolesnik, E; Aziz, F; Benedikt, M; Tripolt, NJ; Wallner, M; Pferschy, PN; von, Lewinski, F; Schwegel, N; Holman, RR; Oulhaj, A; Moertl, D; Siller-Matula, J; Sourij, H
Timing of SGLT2i initiation after acute myocardial infarction.
Cardiovasc Diabetol. 2023; 22(1): 269
Doi: 10.1186/s12933-023-02000-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Müller, A; Moser, O; Sternad, C; Aziz, F; Unteregger, C; Kojzar, H; Mursic, I; Sourij, C; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H
Effects of 8 weeks of aerobic endurance training on functional capacity and metabolic variables in people with type 1 diabetes: A secondary outcome analysis of the ULTRAFLEXI-1 study.
DIABETES OBES METAB. 2023; 25(12): 3826-3830.
Doi: 10.1111/dom.15245
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318.
Doi: 10.1111/dom.14855
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aziz, F; Oulhaj, A; Tripolt, N; Pferschy, P; von-Lewinski, D; Sourij, H
Positive effects of SGLT2 inhibitors on cardiac markers after acute myocardial infarction are similar in patients with and without type 2 diabetes
WIEN KLIN WOCHENSCHR. 2023; 135: S752-S753.
[Oral Communication]
Web of Science
** Aziz, F; Oulhaj, A; Tripolt, N; Pferschy, P; von-Lewinski, F; von-Lewinski, D; Sourij, H
Beneficial effects of SGLT2i after acute myocardial infarction are independent of diabetes status: a sub-group analysis of the EMMY trial
DIABETOLOGIA. 2023; 66(SUPPL 1):S471-S471.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY.
[Poster]
Web of Science
** Curcic, P; Herrmann, M; Pailer, S; Mangge, H; Benedikt, M; von Lewinski, D; Aziz, F; Kolesnik, E; Tripolt, NJ; Pferschy, P; Wallner, M; Zirlik, A; Sourij, H
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute coronary syndrome-a post-hoc analysis of the EMMY trial
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(S2):S361-S361.-ÖKG Jahrestagung; MAY 31-JUN 3, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Birnbaumer, P; Pferschy, P; Tripolt, N; Sourij, H
Measurement Accuracy of simultaneously used rt-CGM compared to isCGM during Exercise in Adults with Type 1 Diabetes: An exploratory Analysis of the ULTRAFLEXI-1 Study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S770-S770.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Birnbaumer, P; Pferschy, PN; Tripolt, N; Sourij, H
Performance of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: an exploratory analysis of the ULTRAFLEXI-1 study
DIABETOLOGIA. 2023; 66(SUPPL 1):S404-S404.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY.
[Oral Communication]
Web of Science
** Tripolt, N; Knoll, L; Pferschy, P; Andritz, E; Obermayer, A; Moser, O; Aziz, F; Sourij, C; Sourij, H
Intermittent Fasting in Patients with Type 2 Diabetes mellitus-2-Year Follow-up Data of the InterFast 2 Study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S764-S765.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Eyileten, C; Wicik, Z; Keshwani, D; Aziz, F; Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Prietl, B; Prüller, F; von, Lewinski, D; De, Rosa, S; Siller-Matula, JM; Postula, M; Sourij, H
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.
Cardiovasc Diabetol. 2022; 21(1): 79
Doi: 10.1186/s12933-022-01517-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Jacan, A; Schauer, M; Aziz, F; Oulhaj, A; Aberer, F; Sourij, C; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocol.
Diabet Med. 2022; 39(6):e14813
Doi: 10.1111/dme.14813
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Tripolt, NJ; Aziz, F; Aberer, F; Forstner, P; Obermayer, AM; Kojzar, H; Kleinhappl, B; Pferschy, PN; Mader, JK; Cvirn, G; Goswami, N; Wachsmuth, N; Eckstein, ML; Müller, A; Abbas, F; Lenz, J; Steinberger, M; Knoll, L; Krause, R; Stradner, M; Schlenke, P; Sareban, N; Prietl, B; Kaser, S; Moser, O; Steinmetz, I; Sourij, H, , COVAC-DM, study, group
Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2022; 24(5):849-858
Doi: 10.1111/dom.14643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Benedikt, M; Wallner, M; Alber, H; Berger, R; Lichtenauer, M; Saely, CH; Moertl, D; Auersperg, P; Reiter, C; Rieder, T; Siller-Matula, JM; Gager, GM; Hasun, M; Weidinger, F; Pieber, TR; Zechner, PM; Herrmann, M; Zirlik, A; Holman, RR; Oulhaj, A; Sourij, H
Empagliflozin in acute myocardial infarction: the EMMY trial.
Eur Heart J. 2022; 43(41):4421-4432
Doi: 10.1093/eurheartj/ehac494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** von, Lewinski, D; Tripolt, NJ; Sourij, H; Pferschy, PN; Oulhaj, A; Alber, H; Gwechenberger, M; Martinek, M; Seidl, S; Moertl, D; Nürnberg, M; Roithinger, FX; Steinwender, C; Stühlinger, M; Zirlik, A; Benedikt, M; Kolesnik, E; Wallner, M; Rohrer, U; Manninger, M; Scherr, D, , ERASe, study, group
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III study.
Am Heart J. 2022; 246:152-160
Doi: 10.1016/j.ahj.2022.01.008
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Moser, O; Aziz, F; Sourij, C; Ziko, H; Lenz, J; Abbas, F; Obermayer, AM; Kojzar, H; Pferschy, PN; Müller, A; Unteregger, C; Leitner, M; Banfic, T; Eckstein, ML; Wachsmuth, N; Kaser, S; Mader, JK; Tripolt, NJ; Sourij, H
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
Diabetes Care. 2022; 45(2): e24-e26.
Doi: 10.2337/dc21-1563
Web of Science
PubMed
FullText
FullText_MUG
** Aziz, F; Eyileten, C; Wicik, Z; Keshwani, D; Aberer, F; Pferschy, P; Tripolt, N; Sourij, C; Prietl, B; Pruller, F; Von-Lewinski, D; De Rosa, S; Siller-Matula, J; Postula, M; Sourij, H
Influence of hypoglycaemia on platelet activation-related microRNAs in people with type 2 diabetes: a stepwise hypoglycaemic clamp study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):230-230.
[Oral Communication]
Web of Science
** Moser, O; Muller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Eckstein, M; Honger, L; Lenz, J; Mursic, I; Sternad, C; Weber, B; Zanker, M; Ziko, H; Pferschy, P; Tripolt, N; Sourij, H
A comparison of Insulin Glargine U300 and Insulin Degludec around spontaneous exercise sessions in people with type 1 diabetes - the ULTRAFLEXI-1 study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):251-251.
[Oral Communication]
Web of Science
** Muller, A; Moser, O; Aberer, F; Abbas, F; Lenz, J; Sternad, C; Eckstein, M; Honger, L; Weber, B; Mursic, I; Zanker, M; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Sourij, H
IMPACT OF ENDURANCE TRAINING ON PHYSICAL PERFORMANCE IN PEOPLE WITH TYPE 1 DIABETES - AN ANALYSIS OF THE ULTRAFLEXI-1 STUDY
DIABETES TECHNOL THE. 2022; 24: A218-A218.
[Poster]
Web of Science
** Muller, A; Moser, O; Aziz, F; Aberer, F; Niedrist, T; Abbas, F; Lenz, J; Sternad, C; Jaruan, O; Glatz, U; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Sourij, H
Impact of endurance exercise on inflammatory markers in adults with type 1 diabetes - a secondary analysis of the -ULTRAFLEXI-1 study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):252-252.
[Poster]
Web of Science
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin treated type 2 diabetes: a randomised controlled trial
DIABETOLOGIA. Abstracts 58th Annual Meeting of the EASD. 2022; 65(SUPPL 1):S276-S276.-58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 19-23, 2022; Stockholm, SWEDEN.
[Oral Communication]
Web of Science
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin-treated type 2 diabetes mellitus a randomized controlled trial
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):252-253.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, A; Sternad, C; Forstner, P; Muller, A; Tripolt, N; Pferschy, P; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Sourij, H
SARS-CoV-2S antibody formation is not impaired in people with type 1 or type 2 diabetes, but the antibody level falls more rapidly in this collective - the -COVAC-DM study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):259-260.
[Oral Communication]
Web of Science
** Sourij, H; Mueller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Eckstein, ML; Lenz, J; Sternad, C; Pferschy, PN; Tripolt, NJ; Ziko, H; Moser, O
Insulin glargine u300 versus insulin degludec around spontaneous exercise sessions in people with type 1 diabetes: the Ultraflexi-1 study
DIABETOLOGIA. 2022; 65(SUPPL 1):S220-S221.
[Oral Communication]
Web of Science
** Eckstein, ML; Moser, O; Tripolt, NJ; Pferschy, PN; Obermayer, AAM; Kojzar, H; Mueller, A; Abbas, F; Sourij, C; Sourij, H
Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis.
Diabetes Obes Metab. 2021; 23(7):1681-1684
Doi: 10.1111/dom.14287
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Eckstein, ML; Mueller, A; Tripolt, NJ; Yildirim, H; Abbas, F; Pferschy, PN; Goswami, N; Aberer, F; Obermayer, A; Pieber, TR; Kojzar, H; Sourij, C; Brunner, M; Niedrist, T; Herrmann, M; Sourij, H
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled Trial.
FRONT ENDOCRINOL. 2021; 12: 656346
Doi: 10.3389/fendo.2021.656346
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Tripolt, N; Pferschy, P; Obermayer, A; Kojzar, H; Mueller, A; Yildirim, H; Sourij, C; Eckstein, M; Sourij, H
Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes-A Prospective Secondary Outcome Analysis.
BIOSENSORS-BASEL. 2021; 11(1):
Doi: 10.3390/bios11010022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer, A; Tripolt, NJ; Aziz, F; Högenauer, C; Aberer, F; Schreiber, F; Eherer, A; Sourij, C; Stadlbauer, V; Svehlikova, E; Brunner, M; Goswami, N; Kojzar, H; Pferschy, PN; Pieber, TR; Sourij, H
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.
Biomolecules. 2021; 11(4):
Doi: 10.3390/biom11040574
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Moser, O; Sourij, C; Aziz, F; Ziko, H; Muller, A; Obermayer, AM; Kojzar, H; Pferschy, PN; Leitner, M; Lenz, J; Abbas, F; Banfic, T; Eckstein, ML; Wachsmuth, N; Tripolt, N; Kaser, S; Mader, JK; Sourij, H
The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):222-222.
[Oral Communication]
Web of Science
** Muller, A; Moser, O; Abbas, F; Lenz, J; Sternad, C; Eckstein, ML; Honger, L; Weber, B; Mursic, I; Zanker, M; Unteregger, C; Kojzar, H; Sourij, C; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H
Effect of several weeks of Endurance Training on physical Performance in People with Type 1 Diabetes - A secondary Analysis of a prospective clinical Trial
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):230-231.
[Oral Communication]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; von Lewinski, F; Kojzar, H; Pferschy, PN; Abbas, F; von Lewinski, D; Lenz, J; Tripolt, NJ; Aberer, F; Sourij, H
Assessment of Insulin Secretion using the C-Peptide/Glucose Ratio (CGR) in People with Type 2 Diabetes mellitus and Insulin Therapy - Data from the Graz Diabetes Register for Biomarker Research (GIRO)
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):227-227.
[Oral Communication]
Web of Science
** Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H
Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228.
[Oral Communication]
Web of Science
** Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Obermayer, AM; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
Diabetes Obes Metab. 2020; 22(2):212-221
Doi: 10.1111/dom.13889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Eckstein, ML; McCarthy, O; Tripolt, NJ; Müller, A; Birnbaumer, P; Pferschy, PN; Hofmann, P; Bracken, RM; Sourij, H; Moser, O
Efficacy of Carbohydrate Supplementation Compared With Bolus Insulin Dose Reduction Around Exercise in Adults With Type 1 Diabetes: A Retrospective, Controlled Analysis.
Can J Diabetes. 2020; 44(8):697-700
Doi: 10.1016/j.jcjd.2020.03.003
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Mueller, A; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H
Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
PLoS One. 2020; 15(9): e0239091-e0239091.
Doi: 10.1371/journal.pone.0239091
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tripolt, NJ; Kolesnik, E; Pferschy, PN; Verheyen, N; Ablasser, K; Sailer, S; Alber, H; Berger, R; Kaulfersch, C; Leitner, K; Lichtenauer, M; Mader, A; Moertl, D; Oulhaj, A; Reiter, C; Rieder, T; Saely, CH; Siller-Matula, J; Weidinger, F; Zechner, PM; von Lewinski, D; Sourij, H; EMMY study group
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
Am Heart J. 2020; 221:39-47
Doi: 10.1016/j.ahj.2019.12.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lennart, M; Moser, EO; Ziko, H; Tripolt, N; Pferschy, PN; Obermayer, AMA; Kojzar, H; Muller, A; Linhart, C; Sourij, C; Sourij, H
The Impact of Glycemia and the Glucose Change Rate on Heart Rate Variability in People with Type 1 Diabetes - A prospective secondary Analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S346-S346.virtuell.
[Poster]
Web of Science
** Muller, A; Moser, O; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H
Halving the Basal Insulin Dose before a Running Event in physically active Adults with Type 1 Diabetes minimizes the Risk of Hypoglycaemia - A prospective, clinical, controlled, Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364.
[Onlinepräsentation]
Web of Science
** Muller, A; Moser, O; Tripolt, N; Pferschy, P; Obermayer, A; Kojzar, H; Yildirim, H; Sourij, C; Eckstein, ML; Sourij, H
Measurement Accuracy of the intermittently-scanned continuous Glucose Monitoring Devices (isCGM) during a glycemic Challenge in Adults with Type 1 Diabetes - A prospective Analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364.
[Poster]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; Kojzar, H; Pferschy, PN; Abbas, F; Lenz, J; Tripolt, N; Aberer, F; Sourij, H
Stages of CKD and cardiovascular Risk in Persons with Diabetes mellitus: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S362-S363.
[Poster]
Web of Science
** Sourij, C; Stauber, R; Aziz, F; Kojzar, H; Obermayer, A; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H
NAFLD in Patients with Diabetes mellitus and Lipid Metabolism Disorders: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S344-S345.
[Poster]
Web of Science
** Tripolt, N; Pferschy, P; Kolesnik, E; Verheyen, N; Ablasser, K; Sailer, S; Breitegger, J; Alber, H; Berger, R; Leitner, K; Lichtenauer, M; Mortl, D; Oulhaj, A; Reiter, C; Rieder, T; Saly, C; Siller-Matula, J; Weidinger, F; Zechner, P; Von Lewinski, D; Sourij, H
Impact of Empagliflozin on cardiac Function and Heart Failure Biomarkers in Patients with acute Myocardial Infarction - EMMY-Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S345-S345.
[Poster]
Web of Science
** Tripolt, NJ; Pferschy, PN; Obermayer, A; Kojzar, H; Obermayer, B; Zanker, M; Sourij, C; Pieber, TR; Moser, O; Eckstein, ML; Riedl, R; Sourij, H
Adaptive insuline and glucose metabolism upon prolonged fasting in non-obese but not in obese individuals.
DIABETOLOGIA. 2020; 63(SUPPL 1):S296-S297.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Poster]
Web of Science
** Tripolt, NJ; Pferschy, PN; Obermayer, A; Kojzar, H; Obermayer-Pietsch, B; Zanker, M; Muller, A; Sourij, C; Moser, O; Eckstein, M; Pieber, T; Riedl, R; Sourij, H
Glucose Metabolism after 12 Hours and 36 Hours of Fasting in People with different Glucose Tolerance.
WIEN KLIN WOCHENSCHR. 2020; 132: S361-S361.
[Poster]
Web of Science
** Aberer, F; Mader, JK; Holzgruber, J; Trummer, C; Schwetz, V; Pandis, M; Pferschy, PN; Greinix, H; Tripolt, NJ; Pieber, TR; Zebisch, A; Sill, H; Wölfler, A; Sourij, H
Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial.
J Diabetes Investig. 2019; 10(2):339-342
Doi: 10.1111/jdi.12919
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Eckstein, ML; Mueller, A; Birnbaumer, P; Aberer, F; Koehler, G; Sourij, C; Kojzar, H; Pferschy, P; Dietz, P; Bracken, RM; Hofmann, P; Sourij, H
Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes-A Randomized Cross-Over Trial.
Nutrients. 2019; 11(6): 1287
Doi: 10.3390/nu11061287
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Svehlikova, E; Brunner, M; Kojzar, H; Pferschy, PN; Pieber, TR; Sourij, H
Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial.
Diabetes Ther. 2019; 10(1):299-309
Doi: 10.1007/s13300-018-0540-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Pferschy, P; Tripolt, N; Sourij, C; Obermayer, AM; Pruller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to Platelet- and Coagulation Activation in Patients with Type 2 Diabetes under Metformin-Monotherapy - Results of hyperinsulinaemic hypoglycaemic Clamp-Study
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S461-S462.
[Poster]
Web of Science
** Aberer, F; Tripolt, N; Pferschy, P; Pruller, F; Riedl, R; Aziz, F; Obermayer, A; Kojzar, H; Stojakovic, T; Scharnagl, H; Oulhaj, A; Sourij, C; Brunner, M; Novak, E; Sourij, H
Acute and prolonged effects of clamp-induced hypoglycaemia on procoagulatory markers in subjects with type 2 diabetes treated with metformin only
DIABETOLOGIA. 2019; 62: S417-S417.
[Poster]
Web of Science
** Eckstein, ML; McCarthy, O; Bracken, RM; Hofmann, P; Kojzar, H; Pferschy, P; Tripolt, N; Kohler, G; Aberer, F; Goswami, N; Moser, O; Sourij, H
Effectiveness of Carbohydrate Supplementation versus Bolus Insulin Reductions to Prevent sports-induced Hypoglycemia: A retrospective controlled Analysis
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S481-S481.
[Oral Communication]
Web of Science
** Eckstein, ML; Moser, O; Mueller, A; Birnbaumer, P; Aberer, F; Koehler, G; Sourij, C; Kojzar, H; Pferschy, P; Dietz, P; Bracken, RM; Hofmann, P; Sourij, H
DECREASED ACCURACY OF THE FREESTYLE (R) LIBRE GLUCOMETER DURING ENDURANCE EXERCISE IN PEOPLE WITH TYPE 1 DIABETES: HYPOGLYCAEMIA IS THE WEAK SPOT
DIABETES TECHNOL THE. 2019; 21: A67-A67.
[Keynote lecture]
Web of Science
** Muller, A; Moser, O; Eckstein, ML; Birnbaumer, P; Aberer, F; Kohler, G; Sourij, C; Kojzar, H; Pferschy, P; Hofmann, P; Sourij, H
Effects of an eight-week Endurance Training on Fructosamine Content in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S483-S483.
[Poster]
Web of Science
** Sourij, C; Obermayer, A; Kojzar, H; Kofler, L; Dzankovic, F; Anoptchenko, V; Pferschy, P; Obermayer-Pietsch, B; Stach, E; Oulhaj, A; Aziz, F; Sourij, H
Persistent Proinsulin Secretion in Patients with DM1-what is really measured?
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471.
[Oral Communication]
Web of Science
** Tripolt, NJ; Stekovic, S; Aberer, F; Url, J; Pferschy, PN; Schröder, S; Verheyen, N; Schmidt, A; Kolesnik, E; Narath, SH; Riedl, R; Obermayer-Pietsch, B; Pieber, TR; Madeo, F; Sourij, H
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial.
Adv Ther. 2018; 35(8):1265-1283
Doi: 10.1007/s12325-018-0746-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Eckstein, ML; Mueller, A; Birnbaumer, P; Aberer, F; Koehler, G; Sourij, C; Kojzar, H; Holler, P; Simi, H; Pferschy, P; Dietz, P; Bracken, RM; Hofmann, P; Sourij, H
Reducing insulin degludec around regular exercise improves time spent in euglycaemia in people with type 1 diabetes: a randomised cross-over trial
DIABETOLOGIA. 2018; 61: S42-S43.-54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 01-05, 2018; Berlin, GERMANY.
[Oral Communication]
Web of Science
** Pferschy, PN; Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, C; Sourij, H
Endobarrier in obese People with Type-2 Diabetes: Short- and Medium-term Effects on the Glucose Metabolism
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):732-732.
[Poster]
Web of Science
** Sourij, C; Pferschy, P; Tripolt, N; Kojzar, H; Weber, B; Aberer, F; Sourij, H
Cardiovascular Disease in Female Patients with Type 2 Diabetes Mellitus at a tertiary Diabetes Center - Data from the Graz Diabetes Register for Biomarker Research (GIRO)
WIEN KLIN WOCHENSCHR. 2017; 129: 178-178.
[Oral Communication]
Web of Science
** Tripolt, N; Aberer, F; Pferschy, P; Sourij, C; Url, J; Hogenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: 161-161.
[Poster]
Web of Science
FullText
** Tripolt, N; Aberer, F; Url, J; Pferschy, P; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: S123-S123.
Web of Science
** Tripolt, N; Pferschy, P; Kojzar, H; Url, J; Weber, B; Sourij, C; Sourij, H
Digitization of Processes in clinical Trials
WIEN KLIN WOCHENSCHR. 2017; 129: 173-174.
[Poster]
Web of Science
** Tripolt, N; Stekovic, S; Aberer, F; Url, J; Pferschy, P; Obermayer-Pietsch, B; Pieber, T; Madeo, F; Sourij, H
Glucose Metabolism after a Fasting Day and after a Day of Eating in healthy Alternate Day Fasting practicing People
WIEN KLIN WOCHENSCHR. 2017; 129: 178-178.
[Oral Communication]
Web of Science